Prostatacancer är den vanligaste orsaken till cancerdöd hos män i Sverige. Cirka 9500 patienter får diagnosen prostatacancer varje år. Prostatacancer diagnostiseras med hjälp av analys av tumörmarkören prostataspecifikt antigen (PSA) i plasma. Syftet med den aktuella studien var att undersöka den preanalytiska stabiliteten av PSA i plasma och att undersöka hur förändrade provtagningsanvisningar och provtagningsrutiner påverkade analysresultat, arbetsförhållanden och patientsäkerhet. Analysmetoden som användes vid studien var electrochemiluminiscence immunoassay (ECLIA), vilken nyttjar ljus för detektion av antigen-/antikroppskomplex. I en första studie visades att centrifugerade PSA-prover med icke avhälld plasma, förvarade i 6o C, kan analyseras upp till 5 dagar efter provtagning. Detta till skillnad från nuvarande metodbeskrivning som kräver avhälld plasma vid analys 24 timmar efter provtagning. En andra studie visade att PSA-prov, förvarat i 6o C, centrifugerat och analyserat 24 timmar efter provtagning gav oförändrade PSA-värden jämfört med PSA-prov som centrifugerats och analyserats direkt efter provtagning. Detta till skillnad från nuvarande metodbeskrivning där prov skall centrifugeras inom 2 timmar och att ocentrifugerat prov skall förvaras i rumstemperatur. Nya automatvalideringsgränser och införandet av laboratoriedataprogrammet Delta-check gav en halvering av antalet analysresultat som ej automatvalideras. Studien visar att PSA var mer stabilt än tidigare förmodats och att förändrade rutiner vid analys av PSA och införande av automatvalidering med Delta-check kan leda till ett förbättrat och mer effektivt arbete för personalen på laboratoriet och ge ökad patientsäkerhet.

The Rhesus (Rh) D antigen is important in transfusion medicine and is the major target in haemolytic disease of the newborn (HDN). The aims of this project were to characterise the helper-T (Th) cell response that drives anti-D alloantibody production in HDN as a first step towards developing an improved or alternative strategy to the current programme of prophylaxis, based on the manipulation the T-cell response. Peripheral blood mononuclear cells (PBMC) were obtained from 22 individuals, who had developed anti-RhD alloantibodies following natural or deliberate immunisation, and from 22 RhD negative and from 12 RhD positive control donors who had not been immunised with RhD. A panel of 69 overlapping synthetic 15-mer peptides, spanning the sequence of the RhD protein, was screed for the ability to stimulate recall proliferation and cytokine production from T-cells in cultures of the PBMC. T cells from all 22 of the alloimmunised donors proliferated in response to RhD peptides and typically multiple peptides were stimulatory. In contrast, only a few minor responses were observed in the control donors. RhD peptides 6, 13, 17, and 28 were identified as immunodominant peptides that stimulated proliferation in over 50% of the alloimmunised donors. Each of these peptides were promiscuous in their ability to stimulate T-cells from donors of the common HLA allotypes in this study. Each immunodominant peptide contains multiple core epitopes and multiple sets of MHC/TCR contacts. Preliminary findings indicate that neither peptides shorter than 15mer length nor analogues can be designed to boost or tolerise alloimmunised donors. The RhD peptides induced a complex pattern of cytokine production from alloreactive T cells. Both IFN-gamma and IL-4 could be produced to the RhD peptides indicative of a Th0 response. In addition, particular peptides elicited the production of the potentially inhibitory cytokines IL-10 or TGFb and not proliferation.

This paper will attempt to determine whether the increased C'4 previously shown following antigen and adjuvant injection could be correlated to antibody increase following antigen injection.

The present study was concerned with the testing of antigenic material derived from a number of streptomycetes in an effort to establish an auxiliary taxonomic scheme based upon cytoplasmic antigen relationships among these organisms.

Integrine sind Transmembranrezeptoren, welche mechanische Signale von der extrazellulären Matrix (ECM) zum Zytoskelett übermitteln ("outside-in-signaling"). Viele molekulare Defekte in der Verbindung zwischen Zytoskelett und ECM erzeugen bekanntermaßen Kardiomyopathien. alpha v Integrin scheint eine Hauptrolle in verschiedenen Prozessen der kardialen Reorganisation zu spielen, wie z.B. Regulation der Zellproliferation, -migration und -differenzierung. Unsere Hypothese war, dass alpha v -Integrin-vermittelte Signale notwendig für die kompensatorische Hypertrophie nach Aortenkonstriktion sind und assoziiert mit der Modulation der Expression von ECM-Proteinen. Dazu wurden Mäuse mit einem spezifischen alpha v Integrin-Inhibitor behandelt und einer Aortenkonstriktion (AB) unterzogen. Nach zwei Tagen und nach sieben Tagen wurden die Mäuse echokardiographisch untersucht und eingehende hämodynamische Untersuchungen wurden durchgeführt. Die Behandlung mit dem alpha v -Integrin-Inhibitor führte zu einer dilatativen Kardiomyopathie und Herzinsuffizienz in den AB-Mäusen, gekennzeichnet durch einen dilatierten linken Ventrikel, schlechte linksventrikuläre Funktion und einer Lungenstauung, wohingegen die scheinbehandelten Tiere eine kompensatorische Hypertrophie des linken Ventrikels zeigten. Untersuchungen der beteiligten Signalwege zeigten eine Aktivierung des p38 MAP-Kinase-Signalwegs, von ERK 1 und -2, der Focal Adhesion Kinase FAK und Tyrosin-Phosphorylierung von c-Src in den Kontrollherzen, was in den Inhibitor-behandelten Herzen fehlte. mRNA-Expressionsanalysen für 96 Gene mittels "Micro-Arrays" ermittelten verschiedene genomische Ziele des alpha v -Integrin-aktivierten Signalwegs. 18 für ECM-Proteine codierende Gene wurden mehr als 2-fach hochreguliert, z.B. Kollagen (8,11-fach ± 2,2), Fibronectin (2,32 ± 094), SPARC (3,78 ± 0,12), ADAMTS-1 (3,51 ± 0,81) und TIMP2 (2,23 ± 0,98), wohingegen die Aktivierung dieser Gene in Inhibitor-behandelten Tieren aufgehoben war. Wir folgern daraus, dass Signalwege unterhalb von alpha v -Integrin, mediiert durch MAP-Kinasen, FAK und c-Src, zu einer verstärkten Expression von ECM-Komponenten führt, welche für die kompensatorische Antwort auf Druckbelastung nötig sind. / Integrins are transmembrane receptors transmitting mechanical signals from the extracellular matrix (ECM) to the cytoskeleton (outside-in-signaling). Many molecular defects in the link between cytoskeleton and ECM are known to induce cardiomyopathies. alpha v integrin appears to play a major role in several processes relevant to remodeling, such as binding and activation of matrix metalloproteinases as well as regulation of cell proliferation, migration, and differentiation. We hypothesized that alpha v integrin-mediated signaling is required for the compensatory hypertrophy after aortic banding (AB) and associated with the modulation of ECM protein expression. Mice were treated in vivo with a specific integrin alpha v inhibitor or vehicle via osmotic minipumps starting 1 day prior to aortic banding (AB). At day 2 and day 7 following AB or sham-operation, the mice were examined by echocardiography and hemodynamic analyses were performed. Treatment of alpha v Integrin inhibitor led to a dilated cardiomyopathy and congestive heart failure in AB mice (dilated left ventricle, depressed LV function, and pulmonary congestion), but not to hypertrophy as observed in mice without inhibitor treatment. Investigation of downstream signaling revealed significant activation of the p38 Mitogen-Activated Protein Kinase (MAPK), the Extracellular signal-Regulated Kinases 1 and 2 (Erk 1/2), Focal Adhesion Kinase (FAK) and tyrosine-phosphorylation of c-Src in mice 7 days after AB. This response was blunted in mice treated with integrin alpha v inhibitor. Microarrays probing for a total of 96 cell adhesion and ECM genes identified various genomic targets of integrin alpha v mediated signalling. 7 days after AB 18 ECM genes were up-regulated more than 2-fold (n=6), e.g. collagen (8.11 ± 2.2), fibronectin (2.32 ± 0.94), secreted protein, acidic and rich in cysteine (SPARC, 3.78 ± 0.12), A disintegrin-like and metalloprotease (reprolysin type) with trombospondin type 1 (Adamts-1, 3.51 ± 0.81) and Tissue inhibitor of metalloproteinase 2 (TIMP2, 2.23 ± 0.98), whereas this up-regulation was abolished in mice that were treatd by integrin alpha v inhibitor via mini pumps. We conclude that signaling downstream of integrin alpha v is mediated by the MAPK, FAK and c-Src pathways leading to an up-regulation of extracelluar matrix components necessary for the compensatory response of the heart under a condition of pressure overload.

Proefschrift Universiteit van Amsterdam. / Met bibliogr., lit. opg. - Met samenvatting in het Nederlands.

Diss. (sammanfattning) Stockholm : Karol. inst., 2001. / Härtill 5 uppsatser.

Diss. (sammanfattning) Stockholm : Karol. inst., 2001. / Härtill 5 uppsatser.

Thesis (Ph.D.)--University of Adelaide, Dept. of Obstetrics and Gynaecology, 2000. / Includes bibliography (leaves 217-239).

Thesis (Ph.D.). / Written for the Dept. of Biochemistry. Title from title page of PDF (viewed 2008/01/11). Includes bibliographical references.